inclacumab inclacumab inclacumab (lc1004-002) (inn) is a human monoclonal antibody designed for the treatment of cardiovascular disease. inclacumabmonoclonal antibodytypewhole antibodysourcehumantargetselectin pclinical dataother nameslc1004-002atc codenoneidentifierscas number1256258-86-2chemspidernoneuniia6734i702lkeggd10356chemical and physical dataformulac6452h9930n1730o2024s42molar mass145465.02 g·mol−1 the antibody is outlicensed by roche.